The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Quimi Daphne since 2014.
This trader's CIK number is 1543031.
At the time of last reporting, Quimi Daphne was the Director of Century Therapeutics, Inc.. (stock ticker symbol IPSC).
Also see all insider trading activities at Century Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | IPSC | 5,000 | $7,655 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2024 | AMLX | 5,000 | $9,435 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | FOLD | 0 | $0 | 11,923 | $152,444 | 0 | $0 |
2022 | FOLD | 0 | $0 | 10,194 | $109,140 | 0 | $0 |
2021 | FOLD | 0 | $0 | 0 | $0 | 16,628 | $48,886 |
2020 | FOLD | 0 | $0 | 31,872 | $445,848 | 82,215 | $248,747 |
2018 | FOLD | 0 | $0 | 24,899 | $363,504 | 24,899 | $203,769 |
2017 | FOLD | 0 | $0 | 7,000 | $99,743 | 7,000 | $99,743 |
2016 | FOLD | 0 | $0 | 8,546 | $68,368 | 27,858 | $22,864 |
2015 | FOLD | 0 | $0 | 23,850 | $310,613 | 38,850 | $184,107 |
2014 | FOLD | 21,050 | $141,153 | 21,050 | $141,153 | 0 | $0 |
1. Century Therapeutics, Inc. (IPSC)
2. Amylyx Pharmaceuticals, Inc. (AMLX)
3. Amicus Therapeutics, Inc. (FOLD)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-09-12 | IPSC | Buy | 5,000 | 1.53 | 7,655 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-05-14 | AMLX | Buy | 2,750 | 1.89 | 5,183 |
2024-05-15 | AMLX | Buy | 2,250 | 1.89 | 4,252 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-01-17 | FOLD | Sale | 5,000 | 12.49 | 62,445 |
2023-01-18 | FOLD | Sale | 6,923 | 13.00 | 89,999 |
2022-08-05 | FOLD | Sale | 5,798 | 12.00 | 69,576 |
2022-06-17 | FOLD | Sale | 4,396 | 9.00 | 39,564 |
2021-03-05 | FOLD | Option Ex | 16,628 | 2.94 | 48,886 |
2020-12-21 | FOLD | Option Ex | 5,000 | 2.94 | 14,700 |
2020-12-21 | FOLD | Sale | 5,000 | 24.09 | 120,475 |
2020-12-15 | FOLD | Option Ex | 30,321 | 3.33 | 100,817 |
2020-10-02 | FOLD | Option Ex | 11,000 | 2.45 | 26,950 |
2020-10-01 | FOLD | Sale | 5,000 | 14.02 | 70,100 |
2020-10-01 | FOLD | Option Ex | 5,000 | 2.94 | 14,700 |
2020-07-01 | FOLD | Sale | 6,872 | 15.47 | 106,323 |
2020-07-01 | FOLD | Option Ex | 19,872 | 2.69 | 53,555 |
2020-01-09 | FOLD | Option Ex | 11,022 | 3.45 | 38,025 |
2020-01-09 | FOLD | Sale | 15,000 | 9.93 | 148,950 |
2018-03-09 | FOLD | Sale | 8,750 | 15.00 | 131,250 |
2018-03-09 | FOLD | Option Ex | 8,750 | 5.96 | 52,150 |
2018-03-01 | FOLD | Option Ex | 8,149 | 4.16 | 33,899 |
2018-03-01 | FOLD | Sale | 8,149 | 14.05 | 114,534 |
2018-01-02 | FOLD | Option Ex | 8,000 | 14.71 | 117,720 |
2018-01-02 | FOLD | Sale | 8,000 | 14.71 | 117,720 |
2017-10-12 | FOLD | Sale | 7,000 | 14.25 | 99,743 |
2017-10-12 | FOLD | Option Ex | 7,000 | 14.25 | 99,743 |
2016-11-09 | FOLD | Option Ex | 2,858 | 8.00 | 22,864 |
2016-11-09 | FOLD | Sale | 8,546 | 8.00 | 68,368 |
2016-01-04 | FOLD | Option Ex | 25,000 | .00 | 0 |
2015-10-01 | FOLD | Option Ex | 11,250 | 13.13 | 147,757 |
2015-10-01 | FOLD | Sale | 11,250 | 13.13 | 147,757 |
2015-09-14 | FOLD | Sale | 2,500 | 18.08 | 45,199 |
2015-07-01 | FOLD | Option Ex | 2,600 | 13.98 | 36,350 |
2015-07-01 | FOLD | Sale | 2,600 | 13.98 | 36,350 |
2015-05-08 | FOLD | Option Ex | 25,000 | .00 | 0 |
2015-05-11 | FOLD | Sale | 7,500 | 10.84 | 81,307 |
2014-11-25 | FOLD | Sale | 3,500 | 8.00 | 28,000 |
2014-11-25 | FOLD | Buy | 3,500 | 8.00 | 28,000 |
2014-10-03 | FOLD | Buy | 6,812 | 7.00 | 47,684 |
2014-10-03 | FOLD | Sale | 6,812 | 7.00 | 47,684 |
2014-09-29 | FOLD | Buy | 10,738 | 6.10 | 65,469 |
2014-09-29 | FOLD | Sale | 10,738 | 6.10 | 65,469 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Quimi Daphne (Director of Century Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.